English
Spanish
Burden of fungal disease in Sweden and Benin presented at ECCMID as GAFFI annual report released
April 23 2018
In Sweden and Benin, the contrast between fungal disease burden is stark, as displayed in two posters at the European Conference of Clinical Microbiology and Infectious Diseases (ECCMID). Sweden is one of the world’s wealthiest countries with a GDP of $51,600 per person (10 million population), whereas Benin is one of the poorest with a GDP of $790 (11 million population). In Benin, an estimated 713,000 school- age children have tinea capitis according to Yolande Sissinto and colleagues, whereas in Sweden tinea capitis is almost absent, although superficial fungal infections were estimated to be common (1,429,000) (Volkan Özenci and colleagues). Asthma rates are also very different among adults: 3.77% in Benin and 8% in Sweden, translating into much higher number of fungal asthma cases in Sweden. Benin has an estimated 80,000 patients with HIV infection compared to the 7000 in Sweden. So while Pneumocystis pneumonia numbers were similar with 315 in Benin, 217 in Sweden, all were in AIDS patients in Benin, whereas only 16 (5%) were in AIDS patients in Sweden.
|
|
Sweden |
Benin |
|
GDP |
$51,600 |
$790 |
|
Population |
10 million |
11 million |
|
Tinea capitis cases in schoolchildren |
Almost absent |
713,000 |
|
Asthma prevalence in adults |
~8% |
~4% |
|
HIV cases |
7,000 |
80,000 |
|
Pneumocystis pneumonia cases |
217 (5% of which in AIDS patients) |
315 (100% of which in AIDS patients) |
These new estimates bring to 75 the number of countries with fungal disease burden estimates conducted by the LIFE Worldwide programme over the last 5 years:
- Published burden papers are available on the GAFFI website: Algeria, Austria, Bangladesh, Belgium, Brazil, Burkina Faso, Canada, Chile, Colombia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, France, Germany, Greece, Guatemala, Hungary, India, Ireland, Israel, Jamaica, Jordan, Kazakhstan, Kenya, Malaysia, Mexico, Nepal, Nigeria, Norway, Pakistan, Peru, Philippines, Portugal, Qatar, Romania, Russia, Senegal, South Korea, Spain, Sri Lanka, Tanzania, Thailand, Trinidad and Tobago, Uganda, UK, Ukraine, Uruguay, Uzbekistan, Vietnam.
- Those not yet published are all available on the LIFE website: Argentina, Australia, Belarus, Benin, Cameroon, China, Congo, Indonesia, Iraq, Iran, Italy, Japan, Madagascar, Malawi, Mongolia, Mozambique, Netherlands, New Zealand, Saudi Arabia, Serbia, Singapore, Sweden, Turkey, Venezuela, Zambia.
Also at ECCMID, GAFFI issued its annual report for 2017. Read the GAFFI press release or full report.
Highlights included:
- The addition of itraconazole, voriconazole and topical natamycin to the WHO Essential Medicines List
- Acceptance of chromoblastomycosis as a WHO Neglected Tropical Disease
- A series of summary papers published in Lancet Infectious Diseases
- Multiple educational programs to raise awareness in Nigeria, Sri Lanka, Pakistan, Mexico, Chile, Iran Denmark, Hungary and the UK.
Dr Nahid Kondori (left) and Dr Volkan Özenci (right) presenting at ECCMID 2018.